Provided by Tiger Trade Technology Pte. Ltd.

Compass Therapeutics, Inc.

5.15
-0.2400-4.45%
Post-market: 5.160.0113+0.22%19:47 EDT
Volume:5.58M
Turnover:28.87M
Market Cap:927.45M
PE:-12.21
High:5.44
Open:5.40
Low:5.14
Close:5.39
52wk High:6.88
52wk Low:1.33
Shares:180.09M
Float Shares:119.00M
Volume Ratio:3.25
T/O Rate:4.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4216
EPS(LYR):-0.4216
ROE:-41.29%
ROA:-25.29%
PB:4.71
PE(LYR):-12.21

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Silence Therapeutics (SLN), RxSight (RXST) and Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 06

Guggenheim Keeps Their Buy Rating on Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 06

Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG) and Compass Therapeutics (CMPX)

TIPRANKS
·
Mar 05

Compass Therapeutics' Q4 Net Loss Narrows

MT Newswires Live
·
Mar 05

Compass Therapeutics reports Q4 EPS (9c), consensus (9c)

TIPRANKS
·
Mar 05

Earnings Flash (CMPX) Compass Therapeutics Posts Q4 Net Loss $0.09 a Share, vs. FactSet Est of $0.09 Loss

MT Newswires Live
·
Mar 05

Compass Therapeutics Q4 EPS $(0.09) Beats $(0.10) Estimate

Benzinga
·
Mar 05

Compass Therapeutics posts FY 2025 R&D expenses of USD 56.0 million, up 32%

Reuters
·
Mar 05

Compass Therapeutics Q4 Income From Operations USD -17.99 Million

THOMSON REUTERS
·
Mar 05

Press Release: Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update

Dow Jones
·
Mar 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 27

Compass Therapeutics Inc. expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
Feb 23

Compass Therapeutics Moves CTX-10726 Into the Clinic: What Early Investors Should Know

TIPRANKS
·
Feb 21

Craig-Hallum bullish on Compass Therapeutics, initiates with a Buy

TIPRANKS
·
Feb 13

Analysts Offer Insights on Healthcare Companies: Teleflex (TFX) and Compass Therapeutics (CMPX)

TIPRANKS
·
Jan 28

Assessing Compass Therapeutics (CMPX) Valuation After A Year Of Strong Share Price Momentum

Simply Wall St.
·
Jan 17

Will Compass Therapeutics’ (CMPX) New Oncology Leaders Redefine Its Path From Pipeline to Commercial Scale?

Simply Wall St.
·
Jan 16

Compass Therapeutics: Strengthening Clinical Pipeline and 2026 Milestones Underscore Buy Rating and Upside Potential

TIPRANKS
·
Jan 11

Compass Therapeutics (CMPX) Gets a Buy from Canaccord Genuity

TIPRANKS
·
Jan 08

Compass Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 06